Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07332312 · ClinicalTrials.gov registry record · NA

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

A NA study, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
71
Enrollment target

NCT07332312: Recruiting NA study, sponsored by University of Southern California.

NCT07332312 is a NA study that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07332312, a NA study, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
71 participants
Enrollment target

Study Summary

This clinical trial develops and tests whether a culturally informed patient navigation program, Community-Focused Patient Navigation (CFPN), works to reduce delays between diagnosis and treatment in American Indian and Alaska Native (AIAN) cancer patients living in rural California. AIAN communities face some of the most severe cancer disparities in the United States, including higher death rates, later-stage diagnoses, and limited access to timely, culturally responsive care. This may be due to barriers such as rural isolation, divided referral systems, or a lack of trust in mainstream healthcare systems. Patient navigation is a care delivery model designed to guide a patient through the healthcare system and address the barriers that prevent patients from accessing timely and effective care. The CFPN program is culturally tailored and designed with AIAN communities in mind. The program provides the patient with a treatment plan based on the patient's unique needs, goals, and barriers. This may be an effective way to reduce delays between diagnosis and treatment in AIAN cancer patients living in rural California.

Primary Outcome

Will compare themes and emerging codes utilizing qualitative coding computer software. A report will summarize participant responses for each focus group and will be discussed with the Toiyabe Indian Health Program (THIP) co-principal investigator (Co-PI) and staff prior to sharing with the Community Advisory Board (CAB) members.

Interventions

  • OTHER Educational Intervention
  • OTHER Electronic Health Record Review
  • OTHER Discussion
  • OTHER Interview

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2026-04-17
Est. Completion 2028-11-13
Phase NA
University of Southern California

617 total trials

What NCT07332312 shows while recruiting

NCT07332312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 4 interventions - of which Educational Intervention is the first listed.

NCT07332312 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07332312 about?

NCT07332312 is a clinical study titled "A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California". This clinical trial develops and tests whether a culturally informed patient navigation program, Community-Focused Patient Navigation (CFPN), works to reduce delays between diagnosis and treatment in American Indian and Alaska Native (AIAN) cancer patients living in rural California. AIAN communitie...

What is the current status of trial NCT07332312?

This trial is currently recruiting. It is a NA study. The enrollment target is 71 participants. The study started on 2026-04-17. Estimated completion is 2028-11-13.

What interventions are being tested in trial NCT07332312?

The interventions under investigation include: Educational Intervention (OTHER), Electronic Health Record Review (OTHER), Discussion (OTHER), Interview (OTHER).

Who is sponsoring clinical trial NCT07332312?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07332312's enrollment target sits among peer trials

71 1102nd of 2000 higher than 898 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07332312, the US trial registry maintained by the National Library of Medicine. NCT07332312 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.